TABLE 2

Primary and secondary outcomes: patient-reported outcomes, mental health status and cognitive assessments

OutcomeCorticosteroidsNo corticosteroidsp-value
Subjects737.5488.9
EQ-5D-5L UI at 1 year0.72±0.250.71±0.250.773
EQ-5D-5L UI change pre-hospital to 1 year−0.11±0.22−0.12±0.220.317
Do you feel fully recovered from COVID-19?Yes223.1 (30.2)139.1 (28.5)0.811
No/not sure465.3 (63.1)299.6 (61.3)
Missing data49.2 (6.7)50.2 (10.3)
Any symptom at 1 yearYes656.8 (89.1)423.6 (86.6)0.508
No39.9 (5.4)21.4 (4.4)
Missing data40.8 (5.5)43.9 (9.0)
Symptom count8.00 (4.00–16.00)9.00 (4.00–16.00)0.671
Fatigue VAS2.00 (0.00–5.00)3.00 (0.00–5.00)0.465
Breathlessness VAS1.00 (0.00–4.00)1.00 (0.00–5.00)0.043
Dyspnoea-12 score5.04±7.225.46±7.830.373
FACIT fatigue score36.79±12.2336.31±12.870.524
MoCA corrected26.90±3.2226.65±3.230.232
MoCA corrected <23Yes49.6 (6.7)41.7 (8.5)0.373
No516.8 (70.1)356.6 (72.9)
Missing data171.1 (23.2)90.6 (18.5)
WG-SS score2.00 (0.00–4.00)2.00 (0.00–4.00)0.613
GAD-7 total score4.75±5.464.91±5.600.631
Anxiety (GAD-7 score >8)Yes159.6 (21.6)110.5 (22.6)0.684
No576.0 (78.1)375.8 (76.9)
Missing data<5<5
PHQ-8 total score6.14±6.256.21±6.390.791
PCL-5 total score13.63±16.7613.76±17.540.901
PTSD (PCL-5 score ≥38)Yes79.6 (10.8)51.0 (10.4)0.866
No650.8 (88.2)431.1 (88.2)
Missing data7.1 (1.0)6.7 (1.4)

Data are n, n (%), mean±sd or median (interquartile range). Percentages are calculated by category after exclusion of missing data for that variable. COVID-19: coronavirus disease 2019; EQ-5D-5L UI: EuroQol-Five Dimensions–Five Levels utility index; FACIT: Functional Assessment of Chronic Illness Therapy; GAD-7: Generalized Anxiety Disorder seven-item; MoCA: Montreal Cognitive Assessment; PCL-5: Post-Traumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders; PHQ-8: Patient Health Questionnaire-8; PTSD: post-traumatic stress disorder; VAS: visual analogue scale; WG-SSL Washington Group Short Set.